ARCHIVES

FDA Approval Of Two Generic Versions Of Taxol Likely To End BMS Exclusivity.

This article is from The Cancer Letter archive.

Vol. 26 No. 35 | September 29, 2000

Download PDF Visit The Full Archive

Related Articles

In Brief: Jordan, Fisher Win Brinker Awards; AFUD Forms 100th Us Too Prostate Cancer Support Group

October 30, 1992

Clinical Trials Approved by NCI CTEP Last Month

August 26, 2011

Phase II Study Shows Positive Results in Reducing Dry Mouth

October 25, 2013

Clinical Societies, Patient Groups Need New Alliance, Glick Proposes to ASCO

May 24, 1996

NCCF, Ad Council plan public service ads on childhood cancer.

November 7, 2003

NCI Division Directors Seek Litton Phaseout, NIH Takeover At Frederick

October 27, 1978